Rakovina Therapeutics to Present at the 6th biennial Canadian Cancer Research Conference

NEXT STORY
Atossa Therapeutics CEO Dr. Steven Quay Emphasizes Importance of Breast Cancer Screening During Breast Cancer Awareness Month
PREV STORY
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

author_avatar
NASDAQ Market News

Ballad Health Chairman and CEO Joins National Healthcare Leaders in Joint Commitment to Transform Healthcare System

author_avatar
NASDAQ Market News

Biocartis Abstract on Performance Idylla(TM) ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting

PRESS RELEASE: Thursday, 15 March 2018, 07:00 CET Biocartis Abstract on Performance Idylla(TM) ctRAS Liquid ...

author_avatar
NASDAQ Market News